INDGN

Indegene Share Price

₹658.10 -1.2 (-0.18%)

22 Jan, 2025 12:36

SIP TrendupStart SIP in INDGN

Start SIP

Performance

  • Low
  • ₹655
  • High
  • ₹666
  • 52 Week Low
  • ₹470
  • 52 Week High
  • ₹736
  • Open Price₹656
  • Previous Close₹659
  • Volume524,438

Investment Returns

  • Over 1 Month + 11.98%
  • Over 3 Month + 0.74%
  • Over 6 Month + 15.39%
  • Over 1 Year + 45.6%
SIP Lightning

Smart Investing Starts Here Start SIP with Indegene for Steady Growth!

Invest Now

Indegene Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 42.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 15,746
  • P/B Ratio
  • 6.7
  • Average True Range
  • 22.73
  • EPS
  • 15.52
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.37
  • RSI
  • 60.3
  • MFI
  • 67.45

Indegene Financials

Indegene Technicals

EMA & SMA

Current Price
₹658.10
-1.2 (-0.18%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 14
  • 20 Day
  • ₹629.49
  • 50 Day
  • ₹628.14
  • 100 Day
  • ₹622.82
  • 200 Day
  • -

Resistance and Support

665.67 Pivot Speed
  • R3 701.03
  • R2 691.37
  • R1 675.33
  • S1 649.63
  • S2 639.97
  • S3 623.93

What's your outlook on Indegene?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Indegene is a global healthcare solutions company providing commercial, medical, and digital transformation services to life sciences companies. It helps pharmaceutical, biotech, and healthcare organizations enhance patient outcomes through data-driven strategies and innovative technology solutions.

Indegene Ltd has an operating revenue of Rs. 2,709.71 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 18% is great, ROE of 23% is exceptional. The company has a reasonable debt to equity of 23%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 8% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 65 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Indegene Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-28 Quarterly Results
2024-08-01 Quarterly Results
2024-05-29 Audited Results

Indegene F&O

Indegene Shareholding Pattern

0%
1.64%
0.1%
5.03%
0%
26.41%
66.82%

About Indegene

  • NSE Symbol
  • INDGN
  • BSE Symbol
  • 544172
  • ISIN
  • INE065X01017

Similar Stocks to Indegene

Indegene FAQs

Indegene share price is ₹658 As on 22 January, 2025 | 12:22

The Market Cap of Indegene is ₹15746.3 Cr As on 22 January, 2025 | 12:22

The P/E ratio of Indegene is 42.2 As on 22 January, 2025 | 12:22

The PB ratio of Indegene is 6.7 As on 22 January, 2025 | 12:22

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23